Health & Medicine
FDA Approves Xiaflex for Peyronie’s disease
The United States Food and Drug Administration has approved Xiaflex (collagenase clostridium histolyticum), a drug to treat men suffering from Peyronie's disease.
Latest Research Articles
Nerves in Stomach Control Eating Habits
Infants Exposed to Loud Music, Seizures could have Poor Brain Development
Dementia Cases to Reach 135 Million by 2050
Depression in Pregnant Women May Affect Babies' Brain Development
Exercise May Boost Cognitive Function in People with Dementia
Healthy and Overweight a Myth, Researchers Suggest
High Cholesterol Fuels Spread of Breast Cancer, Study Suggests
Oxytocin Improves Brain Function in Autistic Children: Yale Study
Vitamin D linked to Brain Damage
Gout is Hereditary Among Taiwanese, Study Suggests
Phobias May Be Inherited, Animal Study Suggests
Lung Cells Grown for First Time with Human Stem Cells
MOST POPULAR
-
Meet Romulus and Remus: Dire Wolf Pups Resurrected with Ancient DNA, Thanks to Colossal Biosciences
-
Meet The Dire Wolf Trio Remus, Romulus And Khaleesi: How A Texas Lab Revived An Extinct Species
-
Massive New Jersey Wildfire Devastates 8,500 Acres, Threatens Wildlife and Communities Amid Historic Drought
-
Is Yerba Mate Nature's Ozempic? Weighing In Risk Vs. Benefits
-
WATCH: 'Ed the Zebra' Airlifted Home After More than a Week on the Run in Tennessee
